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ABSTRACT 
BACKGROUND AND OBJECTIVES: 
          The term  Nephrotic Syndrome refers to classic tetrad of proteinuria, 
hypo-proteinemia,edema and hyperlipidemia.Though it was an ancient 
disease, it was recognized as Nephrosis in early part of 20th century.It has 
been classified as primary,secondary to some other diseases and genetic 
causes.  
        MCNS [minimal change Nephrotic syndrome] is the most common 
primary type of Nephrotic syndrome in children due to podocyte effacement. 
And GCs[glucocorticoids] is the standard therapy for this disease and 
majority of children shows good clinical remission. Some children may 
show relapse [frequent or infrequent],SDNS, SRNS. So, chronic 
consumption of GCs leads to many post-drug effects mainly osteoporosis. 
         This study was done to assess the reduction in bone mineral density 
among children who completed steroid therapy for Nephrotic Syndrome. 
MCNS was taken exclusively for this study.  
METHODS: 
    It was a prospective study done among NS children attended Nephrology 
OPD, IPD and paediatric OPD  and IPD. Initially load was set as 40 – 60 
cases and extended to 100 cases. The GCs were given according to APN 
[is initial therapy for 6 weeks of daily PREDNISOLONE at a single dose 
of 60 mg/m2/day[2mg/kg] in single  or divided doses [maximum dose 
60mg/day] followed by 40mg/m2/day[1.5mg/kg] every other day for an 
additional 6 weeks. All the children with first episode of NS were evaluated 
for reduction in BMD by using bone bio-chemical markers such as serum 
Ca2+.serum Alkaline PO4ase, serum P+ and serum vitamin D3 levels both 
in before drug regimen and post drug. Anthropometry measurements, 
Systemic examinations, CXR, USG, Ur routine for albumin, Ur culture 
sensitivity were done. All children were supplemented with oral calcium. 
RESULTS: 
        The majority of children shows the complete clinical remission of 
disease for gluco-corticoids.The results shows that  the children shows drug 
induced osteoporosis, reduction in bone mineral density.Though the children 
were supplemented with the calcium,they showed reduction in BMD. 
INTERPRETATION AND CONCLUSION: 
           The results shows there was reduction in serum Ca2+ level in pre-
drug status and in complete remission condition  there  was increase in se 
Ca2+ level with oral Ca2+ supplementations, but presented at lower limit. 
The corrected Ca2+ which was biologically available was also improved in 
post-drug condition, but in lower limit[<8.5mg%].Similarly there was 
reduction in vitamin D3 in NS due to disease per se and due to drug effect.    
      In addition to our study, there was increase in other parameters such as 
serum P+ and serum Alkaline PO4ase due to PTH in calcium and Vitamin 
D3 metabolisms. 
  It is to conclude that, NS disease per se in addition to GCs which is the 
standard therapy  for the disease cause combined effect in  reduction in 
BMD. The oral calcium supplementation is not enough to compromise the 
osteoporosis induced by the drug. So, these children should have increased 
intake of dietary calcium. All children should also supplemented by vitamin 
D as per RDA. These children should undergo regular assessment in 
reduction   BMD to know the osteoporosis status, in order to prevent growth 
failure and pathological fractures. 
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